Table 2. Characteristics of the pachychoroid neovasculopathy and neovascular AMD.
| Pachychoroid neovasculopathy | Neovascular AMD | P-value | |
|---|---|---|---|
| Number of patients | 39 (19.5%) | 161 (80.5%) | – |
| Age (years) | 68.7 ± 9.0 | 75.6 ± 8.3 | 5.1 × 10−5 |
| Sex (male:female) | 30:9 | 113:48 | 0.44 |
| Refraction (diopter)* | 0.57 ± 2.08 | 0.10 ± 2.17 | 0.22 |
| RPE abnormality apart from the CNV legion | 35 (89.7%) | 49 (30.4%) | 7.9 × 10−12 |
| Chorodial Vessels dilatation (number of quadrants) | 0.64 ± 0.73 | 0.43 ± 0.58 | 0.093 |
| Choroidal vascular hyperpermeability | 21 (53.8%) | 22 (13.6%) | 4.5 × 10−7 |
| Subfoveal choroidal thickness (μm) | 310`± 53 | 208 ± 100 | 3.4 × 10−14 |
| Polypoidal legion | 22 (56.4%) | 69 (42.9%) | 0.11 |
| Brinkman Index | 482 ± 495 | 537 ± 625 | 0.56 |
AMD: age-related macular degeneration, RPE: retinal pigment epithelium.
CNV: choroidal neovascularization.
*Phakic eyes only; Average of both eyes are presented if both eyes are phakic.